Halliburton Company (HAL) Stock Price & Analysis
Halliburton Company (HAL) closed at USD 33.19 on Thursday, October 22, 2026, down 2.35% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 33.99; the Oct 22, 2026 session ranged USD 32.35–34.41 on volume of 14,288,159 shares. Market capitalization is $27.65B, with a 52-week range of USD 24.92–43.59 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:24 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HAL.md
Latest Earnings Results (HAL)
Halliburton Company (HAL) reported Q1 2026 results on Oct 20, 2026, 7:07:53 AM ET: GAAP EPS $0.55 vs. estimate $0.58 (miss), revenue $5.40B vs. estimate $5.58B (miss). Source: company press release. Nexqual published it 33 min 8 s after release.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q1 2026 | $0.55 (GAAP diluted) | $5.40B | Oct 20, 2026, 7:07:53 AM ET · on Nexqual +33 min 8 s | Press release |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (HAL)
- Last four reported quarters (through Jun 30, 2026): revenue $22.4B, net income $1.60B (7.2% margin), free cash flow $1.73B (SEC filings).
- Valuation: P/E 17.3x (avg 13.6x at the last 3 fiscal year-ends), EV/EBITDA 8.8x, net debt $5.11B.
- 1 of 80 tracked superinvestors hold HAL (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Buy (mean 2.07 on a 1–5 scale) (28 analysts), mean target USD 43.68 (range 29–51).
- Total return with dividends: 1Y +24.4% vs S&P 500 +14.9%; 5Y +41.3% vs S&P 500 +80.3%.
- Next earnings: 2027-01-20, EPS estimate USD 0.64, revenue estimate $5.72B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HAL)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $15.3B | $20.3B | $23.0B | $22.9B | $22.2B | $22.4B |
| Operating income | $1.80B | $2.71B | $4.08B | $3.82B | $2.26B | $2.56B |
| Net income | $1.46B | $1.57B | $2.64B | $2.50B | $1.28B | $1.60B |
| EPS (diluted) | $1.63 | — | — | — | — | — |
| Free cash flow | $1.11B | $1.23B | $2.08B | $2.42B | $1.67B | $1.73B |
| Operating margin | 11.8% | 13.3% | 17.7% | 16.7% | 10.2% | 11.4% |
| Net margin | 9.5% | 7.7% | 11.5% | 10.9% | 5.8% | 7.2% |
| Revenue growth | +5.9% | +32.7% | +13.4% | -0.3% | -3.3% | — |
| Cash + short-term investments | $3.04B | $2.35B | $2.26B | $2.62B | $2.21B | — |
| Total debt | $9.14B | $7.93B | $7.64B | $7.54B | $7.16B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HAL)
P/E 17.3x · P/S 1.2x · EV/EBITDA 8.8x · EV/Sales 1.5x · P/FCF 16.0x · P/B 2.5x · FCF yield 6.24% · Earnings yield 5.79% · Dividend yield (paid, TTM) 2.07% · Buyback yield (TTM) 2.92% · Net debt $5.11B · EV $32.8B
P/E at fiscal year-ends: Dec 2025 18.8x, Dec 2024 9.6x, Dec 2023 12.4x.
Superinvestors (SEC 13F-HR, Q2 2026) (HAL)
1 of 80 tracked investors hold HAL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | 0.39% | $133M | Reduced -3.5% |
Analysts (HAL)
Consensus Buy (mean 2.07 on a 1–5 scale), 28 analysts; mean target USD 43.68 (low 29, high 51).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Freedom Broker | Upgrade | Hold → Buy | $37 → $40 |
| 2026-10-22 | UBS | Target lowered | Neutral | $42 → $41 |
| 2026-10-21 | Jefferies | Target raised | Buy | $47 → $48 |
| 2026-10-21 | Barclays | Target lowered | Overweight | $53 → $51 |
| 2026-10-21 | RBC Capital | Target raised | Outperform | $45 → $46 |
| 2026-10-19 | Piper Sandler | Target lowered | Overweight | $43 → $42 |
| 2026-09-14 | UBS | Target raised | Neutral | $39 → $42 |
| 2026-07-27 | UBS | Target lowered | Neutral | $40 → $39 |
| 2026-07-23 | Argus Research | Target lowered | Buy | $45 → $40 |
| 2026-07-22 | Morgan Stanley | Target lowered | Overweight | $41 → $40 |
| 2026-07-22 | TD Cowen | Target lowered | Buy | $48 → $47 |
| 2026-07-22 | Freedom Broker | Upgrade | Sell → Hold | $32 → $37 |
Total return (dividends reinvested) (HAL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +24.4% | +41.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +24.5% | +7.2% |
| Volatility (annualized) | 32.5% | 42.0% |
| Max drawdown | -27.1% (May 2026→Jul 2026) | -52.3% (Oct 2023→May 2025) |
HAL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.64 | $0.64 | -1.2% | $5.72B | 20 |
| Next quarter (ends Mar 2027) | $0.62 | $0.63 | -1.4% | $5.64B | 16 |
| Current fiscal year (ends Dec 2026) | $2.33 | $2.36 | -1.0% | $22.53B | 23 |
| Next fiscal year (ends Dec 2027) | $2.95 | $2.93 | +0.6% | $23.72B | 25 |
HAL options: expected move
Options price a move of about ±18.7% (±$6.19) by Mar 19, 2027, which includes earnings on Jan 20, 2027; the earnings reaction alone is priced at about ±8.6%.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 44.0% | ±5.2% |
| Nov 6, 2026 | 14 | 38.1% | ±6.2% |
| Nov 13, 2026 | 21 | 36.1% | ±7.1% |
| Nov 20, 2026 | 28 | 36.1% | ±8.1% |
| Nov 27, 2026 | 35 | 34.1% | ±8.6% |
| Dec 4, 2026 | 42 | 26.4% | ±7.4% |
| Dec 18, 2026 | 56 | 33.9% | ±10.7% |
| Jan 15, 2027 | 84 | 33.1% | ±12.7% |
30-day implied volatility 35.5% vs 25.6% realized over the last 30 trading days. Put/call ratio (volume) 0.53. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:24 UTC)
| Price | USD 33.19 |
|---|---|
| Change | ▼ 2.35% (down) |
| Previous Close | USD 33.99 |
| Open | USD 34.3 |
| Day Range | USD 32.35 – 34.41 |
| 52-Week Range | USD 24.92 – 43.59 |
| Volume | 14,288,159 shares |
| Market Cap | $27.65B |
| Exchange | NYQ |
Technical Analysis (HAL)
Nexqual's technical model rates HAL "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:24 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 44.43 (neutral) |
| vs SMA50 | Below (USD 34.13) |
| MACD | -0.12 (negative) |
Analyst Ratings (HAL)
Wall Street analysts rate HAL "Buy" based on 28 analysts, with a mean price target of USD 43.68 (range USD 29–51), per Nexqual as of October 23, 2026 at 09:24 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 28 |
| Mean Target | USD 43.68 |
| High Target | USD 51 |
| Low Target | USD 29 |
| Buy / Hold / Sell | 22 / 5 / 1 |
Earnings (HAL)
| Next Earnings Date | 2027-01-20 |
|---|---|
| EPS Estimate | USD 0.64 |
| Revenue Estimate | $5.72B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.6 vs est 0.58 ▲ beat |
| 2026-06-30 | USD 0.55 vs est 0.54 ▲ beat |
| 2026-03-31 | USD 0.55 vs est 0.5 ▲ beat |
| 2025-12-31 | USD 0.69 vs est 0.55 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Financials & Fundamentals (HAL)
| Total Revenue | $22.48B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +1.80% |
| Gross Margin | +14.97% |
| Operating Margin | +10.94% |
| Profit Margin | +8.90% |
| ROE | +18.78% |
| Debt / Equity | 0.73 |
| Current Ratio | 2.02 |
| Total Cash | $1.84B |
| Total Debt | $8.20B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.73B (7.7% of revenue) |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Financial Health Score (HAL)
Nexqual rates Halliburton Company's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:24 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 15%, operating 11% (last 12 months) |
| Balance Sheet | Strong — $2.05B cash and investments vs $7.16B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $1.73B (last 4 quarters to Jun 2026, SEC), 8% margin |
| Efficiency | Solid — ROE 19%, ROA 8.7% |
Ownership (HAL)
| Insider Ownership | +0.40% |
|---|---|
| Institutional Ownership | +90.21% |
| Shares Outstanding | 833.13M |
| Float | 826.50M |
| Short % of Float | +5.55% |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Leadership (HAL)
Halliburton Company is led by Jeffrey Allen Miller, Chairman of the Board, President & CEO, per Nexqual as of October 23, 2026 at 09:24 UTC.
| Chairman of the Board, President & CEO | Jeffrey Allen Miller |
|---|---|
| Executive VP & CFO | Eric J. Carre |
| Executive VP, COO & Director | Jeffrey Shannon Slocum |
| Senior Director of Investor Relations | David Coleman |
| Senior Vice President of Internal Assurance Services | Jill D. Sharp |
Major Backers & Investors (HAL)
Notable institutional backers of Halliburton Company include SELECT SECTOR SPDR TRUST-State Street Energy Select Sector SPDR ETF, Morgan Stanley, AQR Capital Management, LLC, according to Nexqual as of October 23, 2026 at 09:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SELECT SECTOR SPDR TRUST-State Street Energy Select Sector SPDR ETF | 2.08% |
| Morgan Stanley | 2% |
| AQR Capital Management, LLC | 1.42% |
| Qube Research & Technologies Ltd | 1.34% |
| Fidelity | 1.3% |
| Goldman Sachs | 1.27% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.04% |
| BlackRock | 9.94% |
| State Street | 6.83% |
| Geode Capital | 2.7% |
Source: Nexqual, October 23, 2026 at 09:24 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FTI | TechnipFMC plc | USD 66.82 | ▼ 4.54% |
| TS | Tenaris S.A. | USD 56.37 | ▼ 3.92% |
| BKR | Baker Hughes Company | USD 53.62 | ▼ 4.25% |
| SLB | SLB Limited | USD 49.55 | ▼ 3.03% |
| SEI | Solaris Energy Infrastructure, | USD 58.61 | ▼ 15.51% |
| NOV | NOV Inc. | USD 18.76 | ▼ 2.65% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:24 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt